Skip to main content
Younbok Lee

Dr Younbok Lee PhD

Reader in Gene Therapy for Neurodegenerative Disease

Research interests

  • Neuroscience

Contact details

Biography

Dr Younbok Lee is Reader in Gene Therapy for Neurodegenerative Disease at the Institute of Psychiatry, Psycology & Neuroscience at King's College London.

Gene therapy is a powerful and innovative approach for patients using molecular biology tools to engineer genetic materials. This revolutionary therapy holds promise for treating a wide range of diseases, from rare genetic disorders to neurodegenerative diseases.

Younbok's team is developing gene therapy trials for FTD/ALS and multiple types of gene therapy vectors and delivery strategies. We are also involved in regulatory and operational challenges of gene therapy trials, including early discovery, vector science, and pre-clinical studies. 

He has a strong Industry partnership with King’s College London spinout company AviadoBio. As co-founder of the AviadoBio (Vice-President and Head of Discovery), his lab is developing transformative medicines with industry partners for patients with debilitating and life-threatening neurodegenerative disorders.

Please see his Research Staff Profile for more detail.

Key collaborators

  • Professor Amit Nathwani, University College London
  • Professor Jernej Ule, University College London
  • Professor Christopher Shaw, King's College London
  • Professor James Uney, University of Bristol

Key Publications

View all publications

    News

    AviadoBio and Astella announce exclusive option and license agreement for gene therapy AVB-101 targeting frontotemporal dementia

    The agreement leverages King’s College London spin-out company’s expertise in developing targeted gene therapy for neurodegenerative diseases

    Brain Web

    King's spinout to develop ground-breaking neurodegenerative gene therapy

    AviadoBio is an exciting new spin-out company founded by King’s College London researchers Professor Christopher Shaw, Dr Youn Bok Lee and Dr Do Young Lee

    Chris Shaw brain

      News

      AviadoBio and Astella announce exclusive option and license agreement for gene therapy AVB-101 targeting frontotemporal dementia

      The agreement leverages King’s College London spin-out company’s expertise in developing targeted gene therapy for neurodegenerative diseases

      Brain Web

      King's spinout to develop ground-breaking neurodegenerative gene therapy

      AviadoBio is an exciting new spin-out company founded by King’s College London researchers Professor Christopher Shaw, Dr Youn Bok Lee and Dr Do Young Lee

      Chris Shaw brain